Stock Under $10 with 50-100% upside potential - 14 Days FREE!

WEX To Serve As Presenting Sponsor Of Maine Cancer Foundation’s Tri For A Cure For 2013, 2014 And 2015

Stock quotes in this article: WXS 

WEX Inc. (NYSE: WXS), a leading international provider of physical, digital and virtual corporate card payment solutions, today announced that it will serve as the Presenting Sponsor of the Tri for a Cure event for Maine Cancer Foundation (MCF), a statewide source of cancer grant funding, from 2013 to 2015. At the invitation of MCF executive director, Tara Hill, WEX chairman, president and CEO, Michael E. Dubyak, delivered opening remarks to a group of more than 250 business leaders at the Portland Regional Chamber of Commerce breakfast on December 5 announcing the three year gift.

“Maine Cancer Foundation is deeply committed to cancer research, education and patient support ― and WEX is deeply committed to its mission to find a cure and to support the people of Maine who find themselves affected by this disease,” said Dubyak. “It was our honor and our privilege to serve as the MCF Tri for a Cure Presenting Sponsor in 2012, a record-breaking event that raised $1,200,000. We made the decision to sponsor the Tri for a Cure for the next three years for many reasons including the fact that 100% of funds raised by Maine Cancer Foundation stay in Maine and are reinvested back in our community.”

“We are deeply appreciative of all that WEX has done for MCF and the Maine community and we look forward to making an even greater impact together through the Tri for a Cure event over the next three years,” said Tara Hill, executive director of MCF. “Investing in organizations like MCF is a triple-win for the business community in that it provides outlets for community involvement, actively attracts talent and federal money to the state, and it has a serious and lasting effect on medical research for cancer ― the No. 1 cause of death in our state.”

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 15,387.58 52.30 0.34%
NASDAQ 3,502.12 5.69 0.16%
S&P 500 1,669.16 2.87 0.17%
US 10 Yr 1.944% -0.021

Brokerage Partners

Advertising Partners
Special Features

Free Newsletters from TheStreet

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy. Manage Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs